A carregar...
Recombinant VWF fragments improve bioavailability of subcutaneous factor VIII in hemophilia A mice
Conventional treatment of hemophilia A (HA) requires repetitive IV injection of coagulation factor VIII (FVIII). Subcutaneous administration of FVIII is inefficient because of binding to the extravascular matrix, in particular to phospholipids (PLs), and subsequent proteolysis. To overcome this, rec...
Na minha lista:
| Publicado no: | Blood |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7952839/ https://ncbi.nlm.nih.gov/pubmed/32877516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020006468 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|